Skip to main content
Clinical Trials/NCT07381933
NCT07381933RecruitingNot Applicable

The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body

University of Oulu1 site in 1 country60 target enrollmentStarted: January 23, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Impact of Dietary Berries on Extracellular Vesicle Communication and Host Immunity

Study Overview

Brief Summary

This study examines how berry consumption influences the signaling and distribution of extracellular vesicles (EVs) in the human body. EVs are small bilipid-layered nanoparticles released by cells. EVs carry proteins, lipids, and genetic material, and play a key role in cell-to-cell communication. The composition of EVs reflects the state of their cells of origin, and EVs can affect other cells by delivering their biological contents. EVs offer significant potential for both diagnostics and new therapies.

Recent research has shown that EVs can be found in blood, urine, sweat, and can even cross biological barriers such as the blood-brain barrier and placenta. Many living organisms, including mammalian cells, bacteria, and plants, release EVs. Berries such as cloudberries and lingonberries have demonstrated positive effects on gut microbiota and metabolism, supporting digestive and metabolic health.

In this study, a nutritional intervention will be conducted to investigate the effects of berry consumption on extracellular vesicle signaling of human cells and the gut microbiota, as well as the biodistribution of berry-derived vesicles in the human body.

Detailed Description

This randomized clinical pilot study will enroll 60 healthy adults. Participants will consume either 270 grams of cloudberries or 200 grams of lingonberries (equivalent of 3 dl) daily, for 7 days.

Urine, sweat and faecal samples will be collected from participants both before and after the nutritional intervention. Researchers will isolate EVs from samples and analyze the isolated EVs using transmission electron microscopy (TEM), 16S RNA sequencing, proteomics, and metabolomics. The results obtained from vesicle analyses before and after the nutritional intervention will be compared. Additionally, blood samples will be collected to monitor the immunological status of participants and also information on participants' dietary habits will be collected through a questionnaire.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 18-50
  • Individuals of all heights and weights and both female and male sexes are accepted
  • Written informed consent is required from all study participants
  • Use of probiotics is allowed, but the usage will be reported

Exclusion Criteria

  • Known or suspected allergy to cloudberries or lingonberries
  • Current dermatological or gastrointestinal conditions requiring treatment or interfering the sampling
  • Renal failure
  • Type 1 or type 2 diabetes
  • Pregnancy
  • Immunodeficiency or any condition affecting the immune system, e.g. chronic viral infection
  • Ongoing antibiotic treatment or antibiotic treatment within the past 3 months
  • Immunosuppressive medication or other medication that can be influenced by the intervention

Arms & Interventions

Cloudberry Group

Experimental

30 participants will be allocated to Cloudberry Group.

Intervention: Cloudberries (Dietary Supplement)

Lingonberry Group

Experimental

30 participants will be allocated to Lingonberry Group.

Intervention: Lingonberries (Dietary Supplement)

Outcomes

Primary Outcomes

Impact of Dietary Berries on Extracellular Vesicle Communication and Host Immunity

Time Frame: From baseline (pre-intervention) to Day 7 (post-intervention)

The investigators will assess the effects of berry consumption on the human body, including alterations in gut microbiota composition and immune cell profiles, with a particular focus on changes in extracellular vesicle (EV) signaling.

Secondary Outcomes

  • Changes in Plasma Cytokine Profiles Following Dietary Intervention(Baseline (pre-intervention) to Day 7 (post-intervention))
  • Host Response in Blood Following Dietary Intervention(Baseline (pre-intervention) to Day 7 (post-intervention))
  • Detection and quantification of Berry-Derived Extracellular Vesicles in Human Faeces(From baseline to Day 7 (post-intervention))
  • Detection and Quantification of Berry-Derived Extracellular Vesicles in Human Urine(From baseline to Day 7 (post-intervention))
  • Detection and Quantification of Berry-Derived Extracellular Vesicles in Human Sweat(From baseline to Day 7 (post-intervention))
  • Changes in Extracellular Vesicle Size, Concentration, and Cargo after Nutritional Intervention(From baseline (pre-intervention) to Day 7 (post-intervention))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials